TFF Pharmaceuticals(TFFP)

招股说明书

TFF Pharmaceuticals(TFFP)04-19 05:25

$TFF Pharmaceuticals(TFFP)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-034178  Act: 33  Size: 496 KB 网页链接

当期报告

TFF Pharmaceuticals(TFFP)05-03 05:15

$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001213900-24-039213  Act: 34  Size: 915 KB 网页链接

超过5%股东持股披露

TFF Pharmaceuticals(TFFP)05-09 05:15

$TFF Pharmaceuticals(TFFP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-040937  Act: 34  Size: 107 KB 网页链接

持股变动声明

TFF Pharmaceuticals(TFFP)04-23 08:55

$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035079  Size: 8 KB 网页链接

持股变动声明

TFF Pharmaceuticals(TFFP)04-23 08:55

$TFF Pharmaceuticals(TFFP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001213900-24-035077  Size: 6 KB 网页链接

股东委托书协议

TFF Pharmaceuticals(TFFP)04-23 04:25

$TFF Pharmaceuticals(TFFP)$ DEF 14A Other definitive proxy statements Accession Number: 0001213900-24-034929  Act: 34  Size: 1 MB 网页链接

招股说明书

TFF Pharmaceuticals(TFFP)03-22 20:05

$TFF Pharmaceuticals(TFFP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-24-024937  Act: 33  Size: 414 KB 网页链接

当期报告

TFF Pharmaceuticals(TFFP)03-23 04:35

$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001213900-24-025167  Act: 34  Size: 796 KB 网页链接

其他

TFF Pharmaceuticals(TFFP)04-23 04:25

$TFF Pharmaceuticals(TFFP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-24-034931  Act: 34  Size: 1 MB 网页链接

招股说明书「补充」

TFF Pharmaceuticals(TFFP)04-26 04:35

$TFF Pharmaceuticals(TFFP)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001213900-24-036239  Act: 33  Size: 1 MB 网页链接

Bio News |TFF Pharmaceuticals和Catalent合作开发可吸入药物使用的干粉制剂

牛股小红书2022-03-02 12:13

3月1日，$TFF Pharmaceuticals(TFFP)$ 和$Catalent(CTLT)$ 合作，采用前者专有的薄膜冷冻技术，测试和制造用于一系列生物疗法的干粉制剂。
根据该协议，Catalent将向TFF提供其扩大规模的专业知识和制造能力，作为其首选的开发和制造合作伙伴，Catalent将能够向其客户提供TFF技术，这有可能增加...查看全文

讨论

美港电讯APP2020-09-24 21:21

TFF制药(TFFP.O)：在实验中，发现含亮氨酸的瑞德西韦干粉制剂能更持久地从肺释放到到血浆，公司正与吉利德科学(GILD.O)就此研究结果进行讨论。$TFF Pharmaceuticals(TFFP)$ $吉利德科学(GILD)$ （来自美港电讯APP）查看全文

讨论

冷枪手假亦真2020-08-17 22:34

$TFF Pharmaceuticals(TFFP)$ 今天看你表演了查看全文

讨论

冷枪手假亦真2020-08-14 22:13

$TFF Pharmaceuticals(TFFP)$ 放量突破查看全文

讨论

chuminhua2020-08-14 10:55

8月13日，TFF Pharmaceuticals，Inc.$TFF Pharmaceuticals(TFFP)$ 是一家临床阶段的生物制药公司，专注于根据其专利的薄膜冷冻（TFF）技术平台开发和商业化创新药物产品，宣布已与UNION therapeutics签订了一项全球独家许可协议，将其TFF技术与氯硝柳胺（niclosamide）联合使用。根据协议条款，UNI...查看全文

员工持股计划

$TFF Pharmaceuticals(TFFP)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-052877  Act: 33  Size: 89 KB 网页链接

当期报告

$TFF Pharmaceuticals(TFFP)$ 8-K Current report, item 5.07 Accession Number: 0001213900-24-050881  Act: 34  Size: 212 KB 网页链接

当期报告

$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001213900-24-044746  Act: 34  Size: 484 KB 网页链接

招股说明书

$TFF Pharmaceuticals(TFFP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001213900-24-044749  Act: 33  Size: 351 KB 网页链接

当期报告

$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001213900-24-042919  Act: 34  Size: 280 KB 网页链接

季度财报

$TFF Pharmaceuticals(TFFP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001213900-24-042918  Act: 34  Size: 3 MB 网页链接

超过5%股东持股披露

$TFF Pharmaceuticals(TFFP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-040937  Act: 34  Size: 107 KB 网页链接

超过5%股东持股披露「修订」

$TFF Pharmaceuticals(TFFP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-134251  Act: 34  Size: 78 KB 网页链接

生效批准

$TFF Pharmaceuticals(TFFP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001392  Act: 33  Size: 1 KB 网页链接

当期报告

$TFF Pharmaceuticals(TFFP)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001213900-24-039213  Act: 34  Size: 915 KB 网页链接